Systematic donor blood qualification by flow cytometry would have been able to avoid CLL-type MBL transmission after unrelated hematopoietic stem cell transplantation

European Journal of Haematology

Volumn 88, Issue 3, 2012, Pages 269-272

  Ferrand, Christophe ^a   Garnache Ottou, Francine ^a   Collonge Rame, Marie Agnès ^b   Larosa, Fabrice ^b   Blanc, Michel ^c   Behar, Catherine ^d   Giannoli, Catherine ^e   Garnier, Frédérico ^f   Tiberghien, Pierre ^a   Deconinck, Eric ^b   Rohrlich, Pierre Simon ^b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c Chambery Hospital   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

^f France Greffe de Moelle Registry   (France)

Author keywords

Bone marrow transplantation; Donor CLL; Transmission

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLOSPORIN; CYTARABINE; IMATINIB; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; MELPHALAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BLOOD DONOR; BONE MARROW EXAMINATION; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; CHIMERA; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLONAL VARIATION; CYTOGENETICS; DISEASE TRANSMISSION; DRUG MEGADOSE; DRUG WITHDRAWAL; FLOW CYTOMETRY; FOLLOW UP; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA REMISSION; LYMPHOCYTOSIS; MALE; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; MOLECULAR CLONING; MONOCLONAL B LYMPHOCYTOSIS; MUSCULOSKELETAL DISEASE; MUTATIONAL ANALYSIS; MYELOABLATIVE CONDITIONING; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SCHOOL CHILD; SHORT TANDEM REPEAT; WHOLE BODY RADIATION;

ADULT; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENE REARRANGEMENT, B-LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; MALE; QUALITY CONTROL; UNRELATED DONORS;

EID: 84856964546     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01741.x     Document Type: Article

References (9)

1. Shim YK, Middleton DC, Caporaso NE, et al. Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom 2010;78(Suppl 1):S10-8.
2. Nahi H, Jansson M, Sander B, et al. Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient. Br J Haematol 2008;143:751-3.
3. Flandrin-Gresta P, Callanan M, Nadal N, et al. Transmission of leukemic donor cells by allogeneic stem cell transplantation in a context of familial CLL: should we screen donors for MBL? Blood 2010;116:5077-8.
4. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-56.
5. Rawstron A, Hillmen P, Houlston R. Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients. Semin Hematol 2004;41:192-200.
6. Rawstron AC, Hillmen P. Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract Res Clin Haematol 2010;23:61-9.
7. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
8. Lin K, Glenn MA, Harris RJ, et al. c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications. Cancer Res 2006;66:7801-9.
9. US National Institutes of Health. SEER overview section. Available at: [accessed on 10 July 2011].